Brad C. Klein

Brad C. Klein

Neurology

1151 Old York Road
Suite 200
Abington, PA 19001

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Towards a standardized process of onboarding advanced practice providers into headache medicine practices in the United States: Expert consensus from the American Headache Society practice management committee.

Towards a standardized process of onboarding advanced practice providers into headache medicine practices in the United States: Expert consensus from the American Headache Society practice management committee.

Journal: Headache

Published: August 24, 2025

Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study.

Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study.

Journal: Headache

Published: July 10, 2024

Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period.

Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period.

Journal: Neurology. Clinical practice

Published: January 31, 2024

Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.

Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.

Journal: Neurology

Published: April 21, 2023

Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.

Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.

Journal: Cephalalgia : an international journal of headache

Published: January 09, 2023

Asking the right questions: The value of headache specialty care.

Asking the right questions: The value of headache specialty care.

Journal: Headache

Published: January 23, 2022

Futures Planning at the AAN: Approach and Initial Outcome.

Futures Planning at the AAN: Approach and Initial Outcome.

Journal: Neurology

Published: October 05, 2020

COVID-19 is catalyzing the adoption of teleneurology.

COVID-19 is catalyzing the adoption of teleneurology.

Journal: Neurology

Published: April 03, 2020

Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.

Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.

Journal: Headache

Published: March 27, 2020

Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.

Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.

Journal: Headache

Published: June 24, 2019

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Journal: Cephalalgia : an international journal of headache

Published: March 06, 2018

A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine.

A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine.

Journal: Headache

Published: September 07, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026